Nilotinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CMLCP) with Imatinib Resistance or Intolerance: 2-Year Follow-up Results of a Phase 2 Study.
Year: 2008
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center, University of South Florida, Moffitt Cancer Center, University of Chicago, Heinrich Heine University Düsseldorf, University Hospital Frankfurt, Novartis (United States), Novartis (Switzerland), Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2579504722